Theravance Biopharma Inc (TBPH)
SG&A Expense Growth
6.47%
Fiscal year · Period ending:
TBPH SG&A Expense Growth
Latest reported6.47%period ending
Latest reported6.47%period ending
TBPH FY SG&A Growth (YoY) (0.00% → 6.47%)
Latest values, visible window
High-resolution chart · PNG
TBPH sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 6.4735% | |
| -1.814% | |
| 5.0378% | |
| -32.4515% | |
| -8.5091% | |
| 2.3096% | |
| 9.2965% | |
| 1.5336% | |
| 13.1146% | |
| -6.3124% | |
| 25.8992% | |
| 99.4016% | |
| 39.6735% | |
| 19.679% | |
| 0% |